糖尿病排列病:一种可治疗的运动障碍
Gurunathan Srinivasan1, P Vishaal2, M Chozhan3
1MBBS Student, Department of Neurology, Stanley Medical College, Chennai, Tamil Nadu, India, Orcid: https://orcid.org/0000-0001-5606-102X.
The Journal of the Association of Physicians of India
|March 15, 2025
概括
糖尿病条纹病 (DS) 是糖尿病的一种罕见并发症,它会导致非自愿的运动,就像心脏病-血球症候群 (HCHB) 一样. 在最近的一项案例研究中,有效的血糖控制和药物治疗显著改善了症状.
科学领域:
- 神经学 神经学
- 内分泌学 在内分泌学.
- 医学案例研究 医学案例研究
背景情况:
- 糖尿病条纹病 (DS) 是糖尿病的一种罕见并发症.
- 它的特征是与高血糖相关的 Hemichorea-hemiballismus 综合征 (HCHB).
研究的目的:
- 为了介绍糖尿病条纹病的案例研究.
- 详细介绍DS的临床表现,成像和治疗.
- 强调血糖控制在管理DS中的重要性.
主要方法:
- 分析了一个60岁妇女的病例研究,她的糖尿病控制不良.
- 记录了DS的临床症状,演变和成像特征.
- 治疗包括血糖控制和药物治疗.
主要成果:
- 患者出现了持续的非自愿的高动力运动.
- 治疗导致症状显著改善.
- 影像成像结果是不同的,并有助于诊断.
结论:
- 及时识别和有效治疗对于管理糖尿病条纹病至关重要.
- 血糖管理是DS治疗的基石.
- 这个案例有助于理解和管理DS.
相关概念视频
Parkinson's Disease: Treatment
174
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
174
Parkinson's Disease: Overview
410
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
410
Diabetes: Management and Pharmacotherapy
220
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
220
Diabetes: Symptoms, Diagnosis, and Complications
495
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
495
Diabetes Mellitus: Overview and Type I Subtype
2.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.3K


